Effects of Patient-Driven Lifestyle Modification Using Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: Results From the Randomized Open-label PDF Study

被引:22
|
作者
Choe, Hun Jee [1 ,2 ]
Rhee, Eun-Jung [3 ]
Won, Jong Chul [4 ]
Park, Kyong Soo [1 ,2 ]
Lee, Won-Young [3 ]
Cho, Young Min [1 ,2 ]
机构
[1] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Div Endocrinol & Metab, Dept Internal Med,Sch Med, Seoul, South Korea
[4] Inje Univ, Sanggye Paik Hosp, Div Endocrinol & Metab, Dept Internal Med, Seoul, South Korea
关键词
SENSING TECHNOLOGY; REAL-TIME; NUTRITION; RECOMMENDATIONS; MULTICENTER; MANAGEMENT; ADULTS; CARE;
D O I
10.2337/dc22-0764
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To investigate the effects of patient-driven lifestyle modification using intermittently scanned continuous glucose monitoring (isCGM) in patients with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS We conducted a 12-week, open-label, randomized controlled trial. A total of 126 participants were 1:1 randomized to either the intervention group (structured education + isCGM) or the control group (standard care with blood glucose monitoring). The Self-Evaluation Of Unhealthy foods by Looking at postprandial glucose (SEOUL) algorithm was developed and applied to aid structured education in guiding patients to follow healthy eating behavior depending on the postprandial glycemic response. The primary end point was the change in HbA(1c) level from baseline. RESULTS Implementation of the SEOUL algorithm with isCGM was associated with greater improvement in HbA(1c) than with standard care (risk-adjusted difference -0.50%, 95% CI -0.74 to -0.26, P < 0.001). Participants in the intervention group had a greater reduction in fasting blood glucose and body weight (-16.5 mg/dL, 95% CI -30.0 to -3.0, P = 0.017; -1.5 kg, 95% CI -2.7 to -0.3, P = 0.013, respectively). The score sum for the Korean version of the revised Summary of Diabetes Self-Care Activities Questionnaire increased in both groups but to a greater extent in the intervention group (mean difference 4.8, 95% CI 1.7-8.0, P = 0.003). No severe hyperglycemia or hypoglycemia was reported in either group of patients. CONCLUSIONS Patient-driven lifestyle modification primarily focused on eating behavior using isCGM effectively lowered HbA(1c) levels in patients with T2D.
引用
收藏
页码:2224 / 2230
页数:7
相关论文
共 45 条
  • [21] Effects of basic carbohydrate counting versus standard outpatient nutritional education (The BCC Study): study protocol for a randomised, parallel open-label, intervention study focusing on HbA1c and glucose variability in patients with type 2 diabetes
    Ewers, Bettina
    Bruun, Jens Meldgaard
    Vilsboll, Tina
    BMJ OPEN, 2019, 9 (11):
  • [22] Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial
    Yoneda, Masato
    Honda, Yasushi
    Ogawa, Yuji
    Kessoku, Takaomi
    Kobayashi, Takashi
    Imajo, Kento
    Ozaki, Anna
    Nogami, Asako
    Taguri, Masataka
    Yamanaka, Takeharu
    Kirikoshi, Hiroyuki
    Iwasaki, Tomoyuki
    Kurihashi, Takeo
    Saito, Satoru
    Nakajima, Atsushi
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [23] Patient Controlled, Off-label Use of Continuous Glucose Monitoring: Real-World Medical Costs and Effects of Patient Controlled Sensor Augmented Pump Therapy in Adult Patients Type 1 Diabetes
    Hidefjall, Patrik
    Berg, Lars
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2021, 15 (03): : 575 - 581
  • [24] Development of an information system and mobile application for the care of type 2 diabetes patients at the primary care level for the health sector in Mexico: study protocol for a randomized controlled, open-label trial
    Barengo, Noel C.
    Manuel Apolinar, Leticia
    Estrada Cruz, Norma A.
    Fernandez Garate, Jose E.
    Correa Gonzalez, Roberto A.
    Diaz Valencia, Paula A.
    Cinco Gonzalez, Cecilia Alicia
    Gomez Rodriguez, Jose Alberto
    Cisneros Gonzalez, Nelly
    TRIALS, 2022, 23 (01)
  • [25] Effects of a 6-month, low-carbohydrate diet on glycaemic control, body composition, and cardiovascular risk factors in patients with type 2 diabetes: An open-label randomized controlled trial
    Gram-Kampmann, Eva M.
    Hansen, Camilla D.
    Hugger, Mie B.
    Jensen, Jane M.
    Brond, Jan C.
    Hermann, Anne Pernille
    Krag, Aleksander
    Olsen, Michael H.
    Beck-Nielsen, Henning
    Hojlund, Kurt
    DIABETES OBESITY & METABOLISM, 2022, 24 (04) : 693 - 703
  • [26] Real-world glycaemic outcomes in adult persons with type 1 diabetes using a real-time continuous glucose monitor compared to an intermittently scanned glucose monitor: A retrospective observational study from the Canadian LMC diabetes registry (REAL-CGM-T1D)
    Brown, Ruth E.
    Chu, Lisa
    Norman, Gregory J.
    Abitbol, Alexander
    DIABETIC MEDICINE, 2022, 39 (11)
  • [27] Reply to Letter by Alexander Seibold on "Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring Systems in a Type 1 Diabetes Patient French Cohort: An Observational Study of Clinical Practices" by Yannis Preau, et al. (doi: 10.1089/dia.2020.0674)
    Preau, Yannis
    Armand, Martine
    Galie, Sebastien
    Schaepelynck, Pauline
    Raccah, Denis
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (08) : 598 - 600
  • [28] Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open-label, randomized controlled trial (BEYOND VII)
    Ji, Linong
    Wan, Hailong
    Wen, Binhong
    Wang, Xueying
    Wang, Junfen
    Bian, Rongwen
    Pang, Wuyan
    Tian, Jian
    Wang, Yan
    Bian, Fang
    Gao, Zhengnan
    Condoleon, Alex
    Feng, Wei
    Zhang, Xia
    Cui, Nan
    DIABETES OBESITY & METABOLISM, 2020, 22 (05) : 838 - 846
  • [29] A Multicenter, Randomized, Open-Label Study to Compare the Effects of Gemigliptin Add-on or Escalation of Metformin Dose on Glycemic Control and Safety in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Metformin and SGLT-2 Inhibitors (SO GOOD Study)
    Kim, Hae Jin
    Noh, Jung Hyun
    Moon, Min Kyong
    Choi, Sung Hee
    Ko, Seung-Hyun
    Rhee, Eun-Jung
    Hur, Kyu Yeon
    Jeong, In-Kyung
    JOURNAL OF DIABETES RESEARCH, 2024, 2024
  • [30] Intracerebroventricular enzyme replacement therapy in patients with neuronopathic mucopolysaccharidosis type II: Final report of 5-year results from a Japanese open-label phase 1/2 study
    Seo, Joo-Hyun
    Kosuga, Motomichi
    Hamazaki, Takashi
    Shintaku, Haruo
    Okuyama, Torayuki
    MOLECULAR GENETICS AND METABOLISM, 2023, 140 (04)